Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypertension

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 58 articles:
HTML format
Text format



Single Articles


    November 2017
  1. LUSCHER TF
    From 'essential' hypertension to intensive blood pressure lowering: the pros and cons of lower target values.
    Eur Heart J. 2017;38:3258-3271.
    PubMed     Text format    


    October 2017
  2. RUIZ-HURTADO G, Ruilope LM
    Advantages of sacubitril/valsartan beyond blood pressure control in arterial hypertension.
    Eur Heart J. 2017 Oct 20. doi: 10.1093.
    PubMed     Text format    


  3. LUSCHER TF
    Special issues in heart failure: pulmonary hypertension, deranged potassium levels, and haemodynamic profiles.
    Eur Heart J. 2017;38:2857-2859.
    PubMed     Text format    


    September 2017
  4. SCHMIEDER RE, Wagner F, Mayr M, Delles C, et al
    The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
    Eur Heart J. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. AOKI T, Sugimura K, Tatebe S, Miura M, et al
    Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications.
    Eur Heart J. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2017
  6. WEATHERALD J, Sitbon O, Humbert M
    Validation of a risk assessment instrument for pulmonary arterial hypertension.
    Eur Heart J. 2017 Jun 13. doi: 10.1093.
    PubMed     Text format    


  7. KYLHAMMAR D, Kjellstrom B, Hjalmarsson C, Jansson K, et al
    A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.
    Eur Heart J. 2017 Jun 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  8. PATEL RS, Masi S, Taddei S
    Understanding the role of genetics in hypertension.
    Eur Heart J. 2017 May 25. doi: 10.1093.
    PubMed     Text format    


  9. MAHFOUD F, Schmieder RE, Azizi M, Pathak A, et al
    Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future.
    Eur Heart J. 2017 May 5. doi: 10.1093.
    PubMed     Text format    


    April 2017
  10. NIIRANEN TJ, McCabe EL, Larson MG, Henglin M, et al
    Risk for hypertension crosses generations in the community: a multi-generational cohort study.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. LUSCHER TF
    From systemic and pulmonary hypertension to heart failure: novel drugs and devices.
    Eur Heart J. 2017;38:1087-1090.
    PubMed     Text format    


  12. FUKS KB, Weinmayr G, Basagana X, Gruzieva O, et al
    Long-term exposure to ambient air pollution and traffic noise and incident hypertension in seven cohorts of the European study of cohorts for air pollution effects (ESCAPE).
    Eur Heart J. 2017;38:983-990.
    PubMed     Text format     Abstract available


    March 2017
  13. VAN EMPEL V, Knackstedt C, van Paassen P, Brunner-La Rocca HP, et al
    Just air good enough in pulmonary hypertension?
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format    


  14. ULRICH S, Hasler ED, Saxer S, Furian M, et al
    Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial.
    Eur Heart J. 2017 Mar 11. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  15. GALIE N, Jansa P, Pulido T, Channick RN, et al
    SERAPHIN haemodynamic sub-study: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.
    Eur Heart J. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. VAN DER FEEN DE, Bartelds B, de Boer RA, Berger RM, et al
    Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease.
    Eur Heart J. 2017 Feb 23. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2017
  17. MANCIA G, Oparil S, Whelton PK, McKee M, et al
    The technical report on sodium intake and cardiovascular disease in low- and middle-income countries by the joint working group of the World Heart Federation, the European Society of Hypertension and the European Public Health Association.
    Eur Heart J. 2017 Jan 21. pii: ehw549. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. LIP GY, Coca A
    Hypertension and cardiac arrhythmias.
    Eur Heart J. 2017;38:223-225.
    PubMed     Text format    


  19. KROGAGER ML, Torp-Pedersen C, Mortensen RN, Kober L, et al
    Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data.
    Eur Heart J. 2017;38:104-112.
    PubMed     Text format    


  20. MAHFOUD F, Bakris G, Bhatt DL, Esler M, et al
    Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry.
    Eur Heart J. 2017;38:93-100.
    PubMed     Text format    


  21. PITT B, Rossignol P
    The association between serum potassium and mortality in patients with hypertension: 'a wake-up call'.
    Eur Heart J. 2017;38:113-115.
    PubMed     Text format    


  22. LUSCHER TF
    Hypertension: detection, mechanisms, outcomes, and treatment.
    Eur Heart J. 2017;38:67-69.
    PubMed     Text format    


    December 2016
  23. HOEPER MM, Lam CS, Vachiery JL, Bauersachs J, et al
    Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further researchdagger.
    Eur Heart J. 2016 Dec 23. pii: ehw597. doi: 10.1093.
    PubMed     Text format    


    November 2016
  24. FRANKLIN SS, O'Brien E, Staessen JA
    Masked hypertension: understanding its complexity.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    October 2016
  25. BRUNO RM, Taddei S
    Renal denervation: a blunt weapon against isolated systolic hypertension?
    Eur Heart J. 2016.
    PubMed     Text format    


    July 2016
  26. MAHFOUD F, Bakris G, Bhatt DL, Esler M, et al
    Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  27. LOBO MD, Sobotka PA, Pathak A
    Interventional procedures and future drug therapy for hypertension.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  28. PITT B, Rossignol P
    The association between serum potassium and mortality in patients with hypertension: 'a wake-up call'.
    Eur Heart J. 2016.
    PubMed     Text format    


    May 2016
  29. LUSCHER TF
    Frontiers in congenital heart disease: pulmonary hypertension, heart failure, and arrhythmias.
    Eur Heart J. 2016;37:1407-9.
    PubMed     Text format    


    April 2016
  30. KROGAGER ML, Torp-Pedersen C, Mortensen RN, Kober L, et al
    Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    March 2016
  31. LUSCHER TF
    Update on hypertension: target blood pressure, comorbidities, and outcome.
    Eur Heart J. 2016;37:921-3.
    PubMed     Text format    


  32. MUNZEL T, Gori T, Schmidt F
    CardioPulse. Noise pollution and arterial hypertension.
    Eur Heart J. 2016;37:933-6.
    PubMed     Text format    


  33. EWEN S, Zivanovic I, Bohm M, Mahfoud F, et al
    CardioPulse. Catheter-based renal denervation for hypertension treatment: update 2015.
    Eur Heart J. 2016;37:930-3.
    PubMed     Text format    


  34. LOBO MD, Paton JF
    CardioPulse. The use of devices to treat hypertension.
    Eur Heart J. 2016;37:927-9.
    PubMed     Text format    


  35. OPARIL S
    CardioPulse. The SPRINT trial results.
    Eur Heart J. 2016;37:924-7.
    PubMed     Text format    


  36. LUSCHER TF, Sudano I
    SPRINT: the race for optimal blood pressure control.
    Eur Heart J. 2016;37:937-41.
    PubMed     Text format    


  37. NISHIO M, Hirooka K, Doi Y
    Chinese herbal drug natural indigo may cause pulmonary artery hypertension.
    Eur Heart J. 2016.
    PubMed     Text format    


  38. STOEKENBROEK RM, Boekholdt SM, Luben R, Hovingh GK, et al
    Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study.
    Eur Heart J. 2016;37:880-9.
    PubMed     Text format     Abstract available


    February 2016
  39. HAN QJ, Contijoch F, Forfia PR, Han Y, et al
    Four-dimensional flow magnetic resonance imaging visualizes drastic changes in the blood flow in a patient with chronic thromboembolic pulmonary hypertension after pulmonary thromboendarterectomy.
    Eur Heart J. 2016.
    PubMed     Text format    


  40. SKRIDE A, Sablinskis K, Klepetko W, Lang I, et al
    Choriocarcinoma mimicking chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2016.
    PubMed     Text format    



  41. Erratum to 'Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans'.
    Eur Heart J. 2016.
    PubMed     Text format    


    January 2016
  42. CHIBANA H, Tahara N, Itaya N, Sasaki M, et al
    Optical frequency-domain imaging and pulmonary angioscopy in chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2016.
    PubMed     Text format    


  43. LUSCHER TF
    Pulmonary hypertension, gender issues, and quality of care.
    Eur Heart J. 2016;37:1-3.
    PubMed     Text format    


  44. HUMBERT M, Galie N
    The Ten Commandments for 2015 European Society of Cardiology-European Respiratory Society Guidelines on Pulmonary Hypertension.
    Eur Heart J. 2016;37:5.
    PubMed     Text format    


  45. REGITZ-ZAGROSEK V, Oertelt-Prigione S, Prescott E, Franconi F, et al
    Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes.
    Eur Heart J. 2016;37:24-34.
    PubMed     Text format    


    November 2015
  46. MANCIA G, Kjeldsen SE, Zappe DH, Holzhauer B, et al
    Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    August 2015
  47. PERRONE-FILARDI P, Paolillo S, Costanzo P, Savarese G, et al
    The role of metabolic syndrome in heart failure.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    June 2015
  48. GUTIERREZ A, Bhatt DL
    Medical management of peripheral artery disease in diabetes mellitus.
    Eur Heart J. 2015;36:1494-5.
    PubMed     Text format    


    May 2015
  49. HILFIKER-KLEINER D, Haghikia A, Nonhoff J, Bauersachs J, et al
    Peripartum cardiomyopathy: current management and future perspectives.
    Eur Heart J. 2015;36:1090-7.
    PubMed     Text format     Abstract available


  50. KARANASOS A, Van Mieghem NM, Regar E, Daemen J, et al
    Serial imaging observations of vascular healing in a denervation-induced renal artery dissection.
    Eur Heart J. 2015;36:1040.
    PubMed     Text format    


    April 2015
  51. LUSCHER TF
    An update on heart failure and peripheral arterial disease.
    Eur Heart J. 2015;36:885-7.
    PubMed     Text format    


    March 2015
  52. RAM VS
    CardioPulse: the burden of cardiovascular disease in India.
    Eur Heart J. 2015;36:704-5.
    PubMed     Text format    



  53. Renal denervation more successful when it includes accessory arteries.
    Eur Heart J. 2015;36:536.
    PubMed     Text format    


  54. MASON E, Tofield A
    New analysis of the SYMPLICITY HTN-3 trial.
    Eur Heart J. 2015;36:535.
    PubMed     Text format    


  55. TAYLOR J
    European Society of Cardiology launches Council on Hypertension.
    Eur Heart J. 2015;36:532-3.
    PubMed     Text format    


  56. MESSERLI FH, Bangalore S, Schmieder RE
    Wilder's principle: pre-treatment value determines post-treatment response.
    Eur Heart J. 2015;36:576-9.
    PubMed     Text format    


    February 2015
  57. SCHNOHR P, Marott JL, Kristensen TS, Gyntelberg F, et al
    Ranking of psychosocial and traditional risk factors by importance for coronary heart disease: the Copenhagen City Heart Study.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    January 2015
  58. JACKSON CE, Castagno D, Maggioni AP, Kober L, et al
    Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: